TCR in Fas-Sensitive T Cells from Labial Salivary Glands of Patients with Sjögren's Syndrome

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 1020-1025

  Sumida, Takayuki ^a   Matsumoto, Isao ^a,b   Murata, Hideyuki ^a,b   Namekawa, Takashi ^b   Matsumura, Ryutaro ^c   Tomioka, Hisao ^c   Iwamoto, Itsuo ^b   Saito, Yasushi ^b   Mizushima, Yutaka ^a   Hasunuma, Tomoko ^a   Maeda, Toshiro ^a   Nishioka, Kusuki ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CYTOLOGY; DRUG EFFECT; HUMAN; IMMUNOLOGY; LIP; MINOR SALIVA GLAND; MOLECULAR GENETICS; SJOEGREN SYNDROME; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; HUMANS; LIGANDS; LIP; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME; T-LYMPHOCYTES;

EID: 0031567978     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bloch, K. J., W. W. Buchana, M. J. Wohl, and J. J. Bunim. 1965. Sjögren's syndrome. A clinical, pathological and serological study of sixty-two cases. Medicine 44:187.
2. Adamson, T. C., III, R. I. Fox, D. M. Frisman, and F. V. Howell. 1983. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J. Immunol. 130:203.
3. Zumla, A., M. Mathur, J. Stewart, L. Wilkinson, and D. Isenberg. 1991. T cell receptor expression in Sjögren's syndrome. Ann. Rheum. Dis. 50:691.
4. Pepose, J. S., R. F. Akata, S. C. Pflugfelder, and W. Voight. 1990. Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sjögren's syndrome. Ophthalmology 97:1599.
5. Sumida, T., F. Yonaha, T. Maeda, E. Tanabe, T. Koike, H. Tomioka, and S. Yoshida. 1992. T cell receptor repertoire of infiltrating T cells in lips of Sjögren's syndrome patients. J. Clin. Invest. 89:681.
6. Yonaha, F., T. Sumida, T. Maeda, H. Tomioka, T. Koike, and S. Yoshida. 1992. Restricted junctional usage of T cell receptor Vβ2 and Vβ13 genes, which are overrepresented on infiltrating T cells in the lips of patients with Sjögren's syndrome. Arthritis Rheum. 35:1362.
7. Sumida, T., T. Sakamaki, F. Yonaha, T. Maeda, T. Namekawa, Y. Nawata, K. Takabayashi, I. Iwamoto, and S. Yoshida. 1994. HLA-DR alleles in patients with Sjögren's syndrome over-representing Vβ2 and Vβ13 genes in the labial salivary glands. Br. J. Rheumatol. 33:420.
8. Sumida, T., Y. Kita, F. Yonaha, T. Maeda, I. Iwamoto, and S. Yoshida. 1994. T cell receptor Vα repertoire of infiltrating T cells in labial salivary glands from patients with Sjögren's syndrome. J. Rheumalol. 21:1655.
9. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, S. Nagata, and Y. Seto. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
10. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
11. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediate apoptosis. Nature 356:314.
12. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
13. Rieux-Lancat, F., F. Le Deist, C. Hivroz, I. A. G. Roberts, K. M. Debatin, A. Fischer, and J. P. de Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347.
14. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middelton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutation impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
15. Nakajima, T., H. Aono, T. Hasunuma, K. Yamamoto, T. Shirai, K. Hirohara, and K. Nishioka. 1995. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum. 38:484.
16. Hoa, T. T-M., T. Hasunuma, H. Aono, K. Masuko, T. Kobata, K. Yamamoto, T. Sumida, and K. Nishioka. 1996. Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J. Rheumatol. 23:1322.
17. Matsumura, R., M. Kagami, H. Tomioka, E. Tanabe, T. Sugiyama, M. Sueishi, A. Nakajima, M. Azuma, and K. Okumura. 1996. Expression of ductal Fas antigen in sialoadenitis of Sjögren's syndrome. Clin. Exp. Rheumatol. 44:309.
18. Cifone, M. G., R. De Maria, P. Roncaioli, M. R. Rippo, M. Azuma, L. L. Lanier, A. Santoni, and R. Testi. 1994. Apoptotic signals through CD95 (Fas/Apo-1) activates an acidic Sphingomyelinase. J. Exp. Med. 180:1547.
19. Namekawa, T., K. Kuroda, T. Kato, K. Yamamoto, H. Murata, T. Sakamaki, K. Nishioka, I. Iwamoto, Y. Saitoh, and T. Sumida. 1995. Identification of Ro/ SS-A 52-kD reactive T cells in labial salivary glands from patients with Sjögren's syndrome. J. Rheumatol. 22:2092.
20. Kinoshita, T., J. Imamura, H. Nagai, and K. Shimotohno. 1992. Quantification of gene expression over a wide range by the polymerase chain reaction. Anal. Biochem. 206:231.
21. Lanzillo, J. J. 1991. Chemiluminescent nucleic acid detection with digoxigenin-labeled probes: a model system with probes for angiotensin converting enzyme which detect less than one attomole of target DNA. Anal. Biochem. 194:45.
22. Yamamoto, K., H, Sakoda, T. Nakajima, T. Kato, M. Ohkubo, M. Dohi, Y. Mizushima, K. Ito, and K. Nishioka. 1992. Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int. Immunol. 4:1219.
23. Berke, G. 1995. The CTL's kiss of death. Cell 81:9.
24. + T cell-mediated cytotoxicity. J. Immunol. 152:1127.
25. + T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC) III. CD4+ cytotoxic T cells induce apoptosis of APC. Eur. J. Immunol. 22:267.
26. Ju, S.-T. 1991. Distinct pathways of CD4 and CD8 cells induce rapid target DNA fragmentation. J. Immunol. 146:812.
27. Zychlinsky, A., L. M. Zheng, C.-C. Liu, and J. D.-E. Young. 1991. Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J. Immunol. 146: 393.
28. Yang, Y., M. Mercep, C. F. Ware, and J. D. Ashwell. 1995. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181:1673.
29. Sato, T., S. Irie, S. Kitada, and J. C. Reed. 1995. FAP-1: protein tyrosine phosphatase that associates with Fas. Science 268:411.
30. Vaux, D. L. 1993, Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA 90:786.
31. Sumida, T., T. Namekawa, T. Maeda, and K. Nishioka, New T-cell epitope of Ro/SS-A 52kD protein in labial salivary glands from patients with Sjögren's syndrome. Lancet. In press.
32. Casciola-Rosen, L. A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1317.
33. Sumida, T., F. Yonaha, T. Maeda, Y. Kita, I. Iwamoto, T. Koike, and S. Yoshida. 1994. Expression of sequences homologous to HTLV-I tax gene in the labial salivary glands of Japanese patients with Sjögren's syndrome. Arthritis Rheum. 37:545.
34. Mariette, X., F. Agbalika, M.-T. Daniel, M. Bisson, P. Lagrange, J.-C. Brouet, and F. Morinet. 1993. Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjögren's syndrome. Arthritis Rheum. 36:1423.
35. Terada, K., S. Katamine, K. Eguchi, R. Moriuchi, M. Kita, H. Shimada, I. Yamashita, K. Iwata, Y. Tsuji, S. Nagataki, and T. Miyamoto. 1994. Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet 344: 1116.
36. Talal, N., M. J. Dauphinee, H. Dang, S. S. Alexander, D. J. Hart, and R. F. Garry. 1990. Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy). Arthritis Rheum. 33:774.
37. Yamamoto, K., H. Aono, T. Nakajima, T. Hasunuma, and K. Nishioka. 1995. Oligoclonal proliferation of human T-cell leukemia virus type I infected lymphocytes in lesions of virus-induced arthropathy. Biochem. Biophys. Res. Commun. 208:1040.
38. Mizushima, N., H. Kohasaka, K. Tsubota, I. Saito, and N. Miyasaka. 1995. Diverse T cell receptor β gene usage by infiltrating T cells in the lacrimal glands of Sjögren's syndrome. Clin. Exp. Immunol. 101:33.
39. Legras, F., T. Martin, A.-M. Knapp, and J.-L. Pasquali. 1994. Infiltrating T cells from patients with primary Sjögren's syndrome express restricted or unrestricted T cell receptor Vβ regions depending on the stage of the disease. Eur. J. Immunol. 24:181.
40. Smith, M. D., A. Lamour, A. Boylston, F. C. Lancaster, Y. L. Pennec, A. van Agthoven, G. A. Rook, S. Roncin, P. M. Lydyard, and P. Y. Youinou. 1994. Selective expansion of Vβ families by T cells in the blood and salivary gland infiltrate of patients with primary Sjögren's syndrome. J. Rheumatol. 21: 1832.
41. Murata, H., Y. Kita, A. Sakamoto, I. Matsumoto, R. Matsumura, T. Sugiyama, M. Sueishi, K. Takabayashi, I. Iwamoto, Y. Saitoh, K. Nishioka, and T. Sumida. 1995. Limited T cell receptor repertoire of infiltrating T cells in the kidneys of Sjögren's syndrome patients with interstitial nephritis. J. Immunol. 155:4084.
42. Matsumoto, I., K. Tsubota, Y. Satake, Y. Kita, R. Matsumura, H. Murata, T. Namekawa, K. Nishioka, I. Iwamoto, Y. Saitoh, and T. Sumida. 1996. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome. J. Clin. Invest. 97:1969.